Delivery Order SPE2DB22D2206-SPE2DB25FJF54
Award Date 8/4/25
Potential Completion Date 8/5/25
Potential Value $7.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order on August 1, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Provayblue 50 mg/10 mL ampules. The contract is valued at $4,882.87 with a firm fixed price structure and an ultimate completion date of August 4, 2025. The award represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, which is...
- This contract award, identified as SPE2DB22D3401|SPE2DB25FT0TB, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,319.40 firm-fixed-price delivery order is for the medical product "PROVAYBLUE 50 MG/10 ML AMPULE 10ML" and has a completion date of November 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $8,533.02 to Amerisourcebergen Drug Corporation for the provision of 4561617232 PROVAYBLUE 50 MG/10 ML VIAL 10ML. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance spanning July 27, 2023 through July 28, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of PROVAYBLUE 50 MG/10 ML AMPULE 10ML, a pharmaceutical product, with a ceiling value of $2,210.02 and a period of performance through May 23, 2025. The contract is a Firm Fixed Price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Protopam Chloride 1 GM vials. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,540.93 and an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was competed among...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $18,838.98 from the Defense Logistics Agency's Medical Supply Chain on August 4, 2025. This firm fixed-price delivery order, which is a child contract under a larger vehicle, is set to be completed by August 5, 2025, and represents the company's continued role as a critical federal medical supplier. The award carries no set-aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $82,029.40 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a $163,503.62 delivery order from the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. This firm fixed-price, competitively awarded contract (no set-aside used) is a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order represents a single transaction within AmerisourceBergen's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,963.79 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The delivery order carries no set-aside designation...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $17,876.04 by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price delivery order, issued without a set-aside designation, represents a competitively awarded procurement for pharmaceutical and medical supply products to support federal healthcare needs. The contract is classified as a child award under a larger indefinite delivery vehicle,...